Previous close | 5.05 |
Open | 5.05 |
Bid | 3.10 |
Ask | 7.00 |
Strike | 25.00 |
Expiry date | 2024-12-20 |
Day's range | 5.05 - 5.05 |
Contract range | N/A |
Volume | |
Open interest | 31 |
Here is how Bicycle Therapeutics PLC Sponsored ADR (BCYC) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.
CAMBRIDGE, England & BOSTON, June 03, 2024--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that management will participate in the following investor conferences in June:
Bicycle Therapeutics (BCYC) gains 10% upon entering a PIPE financing agreement with multiple institutional investors, which is expected to generate gross proceeds of $555 million.